These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 34555853)

  • 1. Single-cell polyfunctional proteomics of CD4 cells from patients with AML predicts responses to anti-PD-1-based therapy.
    Abbas HA; Alaniz Z; Mackay S; Cyr M; Zhou J; Issa GC; Alfayez M; Matthews J; Kornblau SM; Jabbour E; Garcia-Manero G; Konopleva M; Andreeff M; Daver N
    Blood Adv; 2021 Nov; 5(22):4569-4574. PubMed ID: 34555853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-Cell CD4 and CD8 T-Cell Secretome Profiling Reveals Temporal and Niche Differences in Acute Myeloid Leukemia Following Immune Checkpoint Blockade Therapy.
    Root JL; Desai PN; Ly C; Wang B; Jelloul FZ; Zhou J; Mackay S; Alfayez M; Matthews J; Pierce S; Reville PK; Daver N; Abbas HA
    Cancer Res Commun; 2024 Mar; 4(3):671-681. PubMed ID: 38391202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nivolumab Plus 5-Azacitidine in Pediatric Relapsed/Refractory Acute Myeloid Leukemia (AML): Phase I/II Trial Results from the Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL) Consortium.
    Verma A; Chi YY; Malvar J; Lamble A; Chaudhury S; Agarwal A; Li HT; Liang G; Leong R; Brown PA; Kaplan J; Schafer ES; Slone T; Pauly M; Chang BH; Stieglitz E; Wayne AS; Hijiya N; Bhojwani D
    Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paired single-B-cell transcriptomics and receptor sequencing reveal activation states and clonal signatures that characterize B cells in acute myeloid leukemia.
    Guo S; Mohan GS; Wang B; Li T; Daver N; Zhao Y; Reville PK; Hao D; Abbas HA
    J Immunother Cancer; 2024 Feb; 12(2):. PubMed ID: 38418394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single cell T cell landscape and T cell receptor repertoire profiling of AML in context of PD-1 blockade therapy.
    Abbas HA; Hao D; Tomczak K; Barrodia P; Im JS; Reville PK; Alaniz Z; Wang W; Wang R; Wang F; Al-Atrash G; Takahashi K; Ning J; Ding M; Beird HC; Mathews JT; Little L; Zhang J; Basu S; Konopleva M; Marques-Piubelli ML; Solis LM; Parra ER; Lu W; Tamegnon A; Garcia-Manero G; Green MR; Sharma P; Allison JP; Kornblau SM; Rai K; Wang L; Daver N; Futreal A
    Nat Commun; 2021 Oct; 12(1):6071. PubMed ID: 34663807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of outcomes in adults with acute myeloid leukemia and KMT2A rearrangements.
    Issa GC; Zarka J; Sasaki K; Qiao W; Pak D; Ning J; Short NJ; Haddad F; Tang Z; Patel KP; Cuglievan B; Daver N; DiNardo CD; Jabbour E; Kadia T; Borthakur G; Garcia-Manero G; Konopleva M; Andreeff M; Kantarjian HM; Ravandi F
    Blood Cancer J; 2021 Sep; 11(9):162. PubMed ID: 34588432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venetoclax plus azacitidine and donor lymphocyte infusion in treating acute myeloid leukemia patients who relapse after allogeneic hematopoietic stem cell transplantation.
    Zhao P; Ni M; Ma D; Fang Q; Zhang Y; Li Y; Huang Y; Chen Y; Chai X; Zhan Y; Li Y; Kang Q; Zhao M; Liu M; Zhang F; Huang S; Wen S; Deng B; Wang J
    Ann Hematol; 2022 Jan; 101(1):119-130. PubMed ID: 34568973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for immune-related adverse events from anti-PD-1 or anti-PD-L1 treatment in an Asian cohort of nonsmall cell lung cancer patients.
    Huang Y; Soon YY; Aminkeng F; Tay SH; Ang Y; Kee ACL; Goh BC; Wong ASC; Soo RA
    Int J Cancer; 2022 Feb; 150(4):636-644. PubMed ID: 34562273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe infections in patients with lymphoproliferative diseases treated with new targeted drugs: A multicentric real-world study.
    Stefania Infante M; Fernández-Cruz A; Núñez L; Carpio C; Jiménez-Ubieto A; López-Jiménez J; Vásquez L; Del Campo R; Romero S; Alonso C; Morillo D; Prat M; Luis Plana J; Villafuerte P; Bastidas G; Bocanegra A; Serna Á; De Nicolás R; Marquet J; Mas-Ochoa C; Cordoba R; García-Suárez J; Comai A; Martín X; Bastos-Oreiro M; Seri C; Navarro-Matilla B; López-Guillermo A; Martínez-López J; Ángel Hernández-Rivas J; Ruiz-Camps I; Grande C;
    Cancer Med; 2021 Nov; 10(21):7629-7640. PubMed ID: 34558211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of major bleeding associated with concomitant use of anticancer drugs and direct oral anticoagulant in patients with cancer and atrial fibrillation.
    Wang CL; Wu VC; Tu HT; Huang YT; Chen SW; Chu PH; Wen MS; Huang HL; Chang SH
    J Thromb Thrombolysis; 2022 Apr; 53(3):633-645. PubMed ID: 34557973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational synergy during leukemia induction remodels chromatin accessibility, histone modifications and three-dimensional DNA topology to alter gene expression.
    Yun H; Narayan N; Vohra S; Giotopoulos G; Mupo A; Madrigal P; Sasca D; Lara-Astiaso D; Horton SJ; Agrawal-Singh S; Meduri E; Basheer F; Marando L; Gozdecka M; Dovey OM; Castillo-Venzor A; Wang X; Gallipoli P; Müller-Tidow C; Osborne CS; Vassiliou GS; Huntly BJP
    Nat Genet; 2021 Oct; 53(10):1443-1455. PubMed ID: 34556857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gilteritinib combination therapies in pediatric patients with FLT3-mutated acute myeloid leukemia.
    McCall D; Roth M; Mahadeo KM; Toepfer L; Nunez C; Short NJ; Daver N; Kadia TM; DiNardo C; Yi JS; Cuglievan B
    Blood Adv; 2021 Dec; 5(23):5215-5219. PubMed ID: 34592761
    [No Abstract]   [Full Text] [Related]  

  • 13. Single cell RNA-seq data and bulk gene profiles reveal a novel signature of disease progression in multiple myeloma.
    Zeng Z; Lin J; Zhang K; Guo X; Zheng X; Yang A; Chen J
    Cancer Cell Int; 2021 Sep; 21(1):511. PubMed ID: 34563174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxaliplatin facilitates tumor-infiltration of T cells and natural-killer cells for enhanced tumor immunotherapy in lung cancer model.
    Xin M; Lin D; Yan N; Li H; Li J; Huang Z
    Anticancer Drugs; 2022 Feb; 33(2):117-123. PubMed ID: 34561996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insight into the catalytic -dependent and -independent roles of METTL3 in sustaining aberrant translation in chronic myeloid leukemia.
    Ianniello Z; Sorci M; Ceci Ginistrelli L; Iaiza A; Marchioni M; Tito C; Capuano E; Masciarelli S; Ottone T; Attrotto C; Rizzo M; Franceschini L; de Pretis S; Voso MT; Pelizzola M; Fazi F; Fatica A
    Cell Death Dis; 2021 Sep; 12(10):870. PubMed ID: 34561421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pembrolizumab May Substantially Up Cervical Cancer Survival.
    Cancer Discov; 2021 Nov; 11(11):2665-2666. PubMed ID: 34561245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Access to cancer medicines deemed essential by oncologists in 82 countries: an international, cross-sectional survey.
    Fundytus A; Sengar M; Lombe D; Hopman W; Jalink M; Gyawali B; Trapani D; Roitberg F; De Vries EGE; Moja L; Ilbawi A; Sullivan R; Booth CM
    Lancet Oncol; 2021 Oct; 22(10):1367-1377. PubMed ID: 34560006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abiraterone acetate versus nonsteroidal antiandrogen with androgen deprivation therapy for high-risk metastatic hormone-sensitive prostate cancer.
    Yanagisawa T; Kimura T; Mori K; Suzuki H; Sano T; Otsuka T; Iwamoto Y; Fukuokaya W; Miyajima K; Enei Y; Sakanaka K; Matsukawa A; Onuma H; Obayashi K; Tsuzuki S; Hata K; Shimomura T; Miki J; Egawa S
    Prostate; 2022 Jan; 82(1):3-12. PubMed ID: 34559410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Predictive Value of Clinical and Molecular Characteristics or Immunotherapy in Non-Small Cell Lung Cancer: A Meta-Analysis of Randomized Controlled Trials.
    Xu Y; Wang Q; Xie J; Chen M; Liu H; Zhan P; Lv T; Song Y
    Front Oncol; 2021; 11():732214. PubMed ID: 34557415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PD-1 inhibition in advanced myeloproliferative neoplasms.
    Hobbs G; Cimen Bozkus C; Moshier E; Dougherty M; Bar-Natan M; Sandy L; Johnson K; Foster JE; Som T; Macrae M; Marble H; Salama M; El Jamal SM; Zubizarreta N; Wadleigh M; Stone R; Bhardwaj N; Iancu-Rubin C; Mascarenhas J
    Blood Adv; 2021 Dec; 5(23):5086-5097. PubMed ID: 34581778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.